Search
Teva Pharmaceutical Industries Ltd
TEVAAdd to Watchlist
38.910USD
-0.750-1.89%
Market hours 10/06, 15:43（ET）
45.34BMarket Cap
31.60P/E TTM
Teva Pharmaceutical Industries Ltd (TEVA) Stock Price Target & Forecast
Analyst Rating
Based on 2 analysts giving stock ratings to Teva Pharmaceutical Industries Ltd in the past month.
Strong Buy
1 Strong Buy
1 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
41.750USD+5.62%
TEVA Analyst Recommendation Trends
In the current month, TEVA has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. TEVA average Analyst price target in the last month is 41.750.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
1
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
1
1
1
1
1
1
1
TEVA Analyst Rating for Peer Comparison
Updated: Oct 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Amgen Inc
AMGN
4
12
18
2
1
37
Biogen Inc
BIIB
7
17
12
1
0
37
Eli Lilly and Co
LLY
10
17
6
1
0
34
AbbVie Inc
ABBV
8
19
6
0
0
33
Vertex Pharmaceuticals Inc
VRTX
10
17
5
0
1
33
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Regeneron Pharmaceuticals Inc
REGN
6
15
10
0
0
31
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Merck & Co Inc
MRK
7
16
8
0
0
31
Alnylam Pharmaceuticals Inc
ALNY
5
18
7
0
0
30
Financial Forecasting
Based on analysts' estimates, TEVA EPS is projected to reach 0.687 in FY2026Q3, following reported EPS of -0.494 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
0.68
0.48
0.25
0.69
0.74
Actual
0.42
0.32
-0.49
--
--
Surprise
-38.45%
-33.18%
-300.44%
--
--
FAQs
What is Teva Pharmaceutical Industries Ltd's expected revenue for the next quarter?
Teva Pharmaceutical Industries Ltd's expected revenue is 4.21B.
What is Teva Pharmaceutical Industries Ltd's price target?
Analysts forecast that Teva Pharmaceutical Industries Ltd's price target is USD 44.83, with the highest forecast at USD 55.00 and the lowest forecast at USD 33.00.
How have Teva Pharmaceutical Industries LtdTEVA's recent earnings per share performed?
The market expectation was USD -0.49, while Teva Pharmaceutical Industries LtdTEVA's earnings per share (EPS) for the previous quarter was USD 0.32. EPS for the next quarter is expected at USD 0.69.
What is the analyst rating for Teva Pharmaceutical Industries Ltd?
Based on the ratings of Teva Pharmaceutical Industries Ltd's stock from 2 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.